Skip to main content
. 2022 Feb 11;10:802217. doi: 10.3389/fped.2022.802217

Table 4.

Changes of MMP-2, and MMP-9 levels before and after treatment.

KD Sub group p-value
KD-CAL KD-NonCAL
ΔMMP-2 (pg/ml) 409.32 ± 213.43*** 412.84 ± 197.48*** 404.25 ± 204.19*** 0.037
ΔMMP-9 (pg/ml) 05.43 ± 135.62*** 210.77 ± 117.64*** 186.37 ± 128.02*** 0.012

MMP-2, 9, metalloproteinases-2, 9; KD, Kawasaki disease; CALs, coronary artery lesions.

***

p-value of <0.001 pre-treatment vs. post-treatment.